| View |
DR-XY48365_PI_01.pdf
|
DR-XY48365
|
Tolvaptan
|
Jinarc
|
30mg
|
Tablet
|
Diuretic (Vasopressin Antagonist)
|
Otsuka Pharmaceutical Co., Ltd. (Tokushima Itano
Factory)
|
Japan
|
Monitored Release
|
20 September 2022
|
20 September 2027
|
| View |
|
HRP-549
|
Isopropyl Alcohol
|
Unbranded
|
70mL per 100mL (70% v/v)
|
Topical Solution
|
Antiseptic/Disinfectant
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
27 October 2024
|
23 September 2029
|
| View |
|
DR-XY48366
|
Ketorolac Tromethamine
|
Kabirol
|
30 mg/mL
|
Solution for Injection (I.V./I.M.)
|
-
|
PT. Ethica Industri Farmasi (PT. Ethica)
|
Indonesia
|
Initial
|
20 September 2022
|
20 September 2027
|
| View |
|
DRP-12655
|
Pregabalin
|
None
|
50 mg
|
Capsule
|
Antiepileptic
|
Phil. United Pharma Corp.
|
Philippines
|
Initial
|
19 September 2022
|
19 September 2027
|
| View |
|
DRP-12618
|
Ceftriaxone (as Sodium)
|
None
|
1g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
Initial
|
21 September 2022
|
21 September 2027
|
| View |
|
DRP-12656
|
Pregabalin
|
Pregab
|
50 mg
|
Capsule
|
Anti-epileptic
|
Phil. United Pharma Corp.
|
Philippines
|
Initial
|
19 September 2022
|
19 September 2027
|
| View |
|
DRP-12718
|
Norepinephrine (As Bitartrate)
|
Norbipine
|
1 mg/mL (4 mg/4 mL)
|
Solution for I.V. Infusion
|
Adrenergic and dopaminergic agent
|
Ubi Pharma Inc. (Hsinchu Plant)
|
Taiwan
|
Initial
|
28 September 2022
|
28 September 2025
|
| View |
|
DRP-12657
|
Ceftriaxone (As Sodium)
|
Accexone
|
2g
|
Powder For Injection (IM/IV)
|
-
|
Medisure Laboratories Pakistan (Pvt.) Ltd.
|
Pakistan
|
Initial
|
19 September 2022
|
19 September 2027
|
| View |
|
DRP-12675
|
Imatinib (as Mesilate)
|
Imasil-100
|
100 mg
|
Film-Coated Tablet
|
BCR-ABL tyrosine kinase inhibitor
|
Cipla Limited (Unit X)
|
India
|
Initial
|
02 September 2022
|
22 September 2027
|
| View |
|
DRP-12717
|
Ketorolac trometamol
|
Ketrian
|
30 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Non-steroidal Anti-Inflammatory Agent (NSAID)
|
Farbe Firma
|
India
|
Initial
|
28 September 2022
|
28 September 2027
|
| View |
|
DRP-12676
|
Imatinib (as Mesilate)
|
Imasil-400
|
400 mg
|
Film-Coated Tablet
|
-
|
Cipla Limited (Unit X)
|
India
|
Initial
|
22 September 2022
|
22 September 2027
|
| View |
|
DRP-12624
|
Pantoprazole (as sodium sesquihydrate)
|
Pantosaph-40
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
16 September 2022
|
16 September 2027
|
| View |
|
DRP-12625
|
Pantoprazole (as sodium sesquihydrate)
|
Pantosaph-20
|
20 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
16 September 2022
|
16 September 2027
|
| View |
|
DR-XY48364
|
Mecobalamin
|
None
|
500 mcg/mL
|
Solution for Injection (IM/IV)
|
Vitamin
|
Zee Laboratories Limited
|
India
|
Initial
|
28 September 2022
|
28 September 2027
|
| View |
|
DRP-12720
|
Pramipexole (as hydrochloride)
|
Prepexol
|
180 mcg
|
Tablet
|
Dopamine agonist
|
Stalllion Laboratories Pvt. Ltd.
|
India
|
Initial
|
28 September 2022
|
28 September 2027
|
| View |
|
DRP-12707
|
Telmisartan
|
Merit
|
40 mg
|
Tablet
|
-
|
Krka, d.d., Novo mesto
|
Slovenia
|
Initial
|
27 September 2022
|
27 September 2027
|
| View |
|
DR-XY38044
|
Amlodipine (As Besilate)
+
Hydrochlorothiazide
|
Amvasc Plus
|
10 mg/12.5 mg
|
Tablet
|
-
|
Amherst Laboratories Inc.
|
Philippines
|
Automatic Renewal (Correction)
|
23 September 2022
|
02 June 2025
|
| View |
|
DRP-12722
|
Meropenem (as trihydrate)
|
Nemosea-500
|
500 mg
|
Powder for Solution for Intravenous (I.V.)
Injection
|
-
|
Brooks Laboratories Limited
|
India
|
Initial
|
28 September 2022
|
28 September 2027
|
| View |
|
DR-X7076
|
Guiafenesin + Chlorphenamine Maleate + Phenylpropanolamine Hcl + Sodium Citrate + Ammonium Chloride
|
Glychlor
|
50mg+2mg+10mg+200mg+30mg per 5mL
|
Syrup
|
Nasal Decongestant/Antihistamine/Expectorant
|
Philmed Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 September 2022
|
22 November 2027
|
| View |
|
DRP-5882-05
|
Omeprazole (as sodium)
|
Robimep
|
40 mg
|
Lyophilized Powder for IV Injection/Infusion
|
Proton Pump Inhibitor
|
Gufic Biosciences Limited
|
India
|
Renewal
|
28 September 2022
|
09 December 2027
|